P867: CT103A, A NOVEL FULLY HUMAN BCMA-TARGETING CAR-T CELLS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS OF PHASE 1B/2 STUDY (FUMANBA-1)

• Chunrui LI,
• DI Wang,
• Yongping Song,
• He Huang,
• Jianyong LI,
• Bing Chen,
• Jing Liu,
• Yujun Dong,
• Kai Hu,
• Peng Liu,
• XI Zhang,
• Jianqing MI,
• Zhenyu LI,
• Kaiyang Ding,
• Aining Xu,
• Songbai Cai,
• Jingjing Guo,
• Hongyu Gui,
• Wen Wang,
• Lugui Qiu

Affiliations

Chunrui LI

1 Tongji Hospital of Tongji Medical College, Huazhong University of Science, Department of Hematology, Wuhan, China

DI Wang

1 Tongji Hospital of Tongji Medical College, Huazhong University of Science, Department of Hematology, Wuhan, China

Yongping Song

2 the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Department of Hematology, Zhengzhou, China

He Huang

3 The First Affliated Hospital, Zhejiang University, Department of Hematology, Hangzhou, China

Jianyong LI

4 Jiangsu Province Hospital, Department of Hematology, Nanjing, China

Bing Chen

5 Nanjing Drum Tower Hospital, Department of Hematology, Nanjing

Jing Liu

6 Third Xiangya Hospital of Central South University, Department of Hematology, Changsha

Yujun Dong

7 Peking University First Hospital, Department of Hematology, Beijing, China

Kai Hu

8 Beijing GoBroad Boren Hospital, Department of Adult Lymphoma, Beijing, China

Peng Liu

9 Zhongshan Hospital, Fudan University, Department of Hematology, Shanghai, China

XI Zhang

10 Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Department of Hematology, Chongqing, China

Jianqing MI

11 State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Shanghai Institute of Hematology, Ruijin Hospital Affiliated With Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Zhenyu LI

12 The Affiliated Hospital of Xuzhou Medical University, Department of Hematology, Xuzhou, China

Kaiyang Ding

13 The First Aìliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Department of Hematology, Hefei, China

Aining Xu

14 Nanjing IASO Biotherapeutics Ltd, Shanghai, China

Songbai Cai

14 Nanjing IASO Biotherapeutics Ltd, Shanghai, China

Jingjing Guo

14 Nanjing IASO Biotherapeutics Ltd, Shanghai, China

Hongyu Gui

14 Nanjing IASO Biotherapeutics Ltd, Shanghai, China

Wen Wang

14 Nanjing IASO Biotherapeutics Ltd, Shanghai, China

Lugui Qiu

15 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Tianjin, China